{"id":"W2551609581","doi":"10.1097/mph.0000000000000703","title":"Nivolumab in the Treatment of Refractory Pediatric Hodgkin Lymphoma","year":2016,"lang":"en","type":"article","venue":"Journal of Pediatric Hematology/Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"ca_institutions":"Child and Family Research Institute; University of British Columbia; BC Children's Hospital; BC Cancer Agency","funders":"Bristol-Myers Squibb","keywords":"Medicine; Nivolumab; Renal cell carcinoma; Oncology; Lymphoma; Adverse effect; Internal medicine; Cancer; Refractory (planetary science); Progressive disease; Disease; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001928032,0.0002272257,0.0004547648,0.0002026282,0.0003471781,0.0002299518,0.000192782,0.0004055576,0.0004506948],"category_scores_gemma":[0.0003906407,0.0001034216,0.0002713817,0.0001470265,0.0002221139,0.0002180104,0.000204224,0.000865167,0.0001785702],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005623191,"about_ca_system_score_gemma":0.0004602969,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009718006,"about_ca_topic_score_gemma":0.003840228,"domain_scores_codex":[0.9998994,0.00003572548,0.00001337331,0.00001031701,0.0000157568,0.00002547571],"domain_scores_gemma":[0.9998695,0.00004120726,0.00002466495,0.000007196758,0.0000109873,0.00004646202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.004742398,0.0009650818,0.07599894,0.001927994,0.0004417472,0.2237233,0.001630147,0.005182391,0.07949007,0.002642649,0.01387066,0.5893846],"study_design_scores_gemma":[0.002898945,0.01618566,0.1212049,0.001188981,0.001037798,0.5557365,0.001501573,0.009267915,0.08131748,0.00257812,0.2069894,0.00009273396],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9242854,0.06190146,0.002362023,0.002651549,0.0003053947,0.0001074716,0.0001136006,0.0001912743,0.008081804],"genre_scores_gemma":[0.9872177,0.009835442,0.001304614,0.0006040354,0.0001249577,0.00002794791,0.00009170463,0.00001962164,0.0007738682],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009718006,"threshold_uncertainty_score":0.004079998,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03797851027425286,"score_gpt":0.357507728957379,"score_spread":0.3195292186831261,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}